Position in BBIO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$254,603,846
-$110,609,060 QoQ
Shares Held
3,418,419
-30.5% QoQ
Ownership
1.75%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 472 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. BBIO ranks #17 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in BBIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $254,603,846 | 3,418,419 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $365,212,906 | 4,918,030 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $337,513,884 | 4,412,523 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $203,082,335 | 3,909,941 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $158,970,623 | 3,681,580 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $121,095,045 | 3,502,894 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $93,781,495 | 3,417,693 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $86,919,141 | 3,413,949 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $83,346,059 | 3,290,409 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $88,519,167 | 2,862,845 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $109,570,962 | 2,714,168 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $66,219,816 | 2,511,180 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $41,613,164 | 2,419,370 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $37,357,359 | 2,253,158 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,742,211 | 2,065,907 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $19,520,937 | 1,963,877 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,891,649 | 1,970,446 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $18,113,446 | 1,784,576 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $32,149,215 | 1,927,411 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $91,259,873 | 1,947,085 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $111,187,260 | 1,823,938 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $102,438,151 | 1,662,957 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $86,023,260 | 1,209,721 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $43,472,735 | 1,158,655 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $23,901,010 | 732,935 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $20,959,373 | 722,737 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||